Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Goodin

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cancers|November 12, 2013
Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient MiceXi Zheng, Xiao-Xing Cui, Tin Oo Khor, et al.
Biological & Pharmaceutical Bulletin|August 4, 2017
Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in VivoZhen-Shi Wang, Hua-Rong Huang, Lan-Yue Zhang, et al.
Journal of Oncology Practice|May 3, 2011
Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panelSusan Goodin, Niesha Griffith, Beth Chen, et al.
Anticancer Research|July 2, 2014
Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivoHuarong Huang, Xiao-Xing Cui, Shaohua Chen, et al.
Oncology Reports|December 4, 2013
Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxibHuaqian Wang, Xiao-Xing Cui, Susan Goodin, et al.
European Journal of Pharmacology|December 28, 2020
Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cellsXue-Tao Xu, Jie Chen, Xiang Ren, et al.
Investigational New Drugs|August 8, 2019
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumorsMark N Stein, Susan Goodin, Murugeson Gounder, et al.
Journal of Agricultural and Food Chemistry|October 17, 2014
Potent inhibitory effect of δ-tocopherol on prostate cancer cells cultured in vitro and grown as xenograft tumors in vivoHuarong Huang, Yan He, Xiao-Xing Cui, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 19, 2014
Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trialJohn P Richie, Arun Das, Ana M Calcagnotto, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumorsJanice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancers|November 12, 2013
Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient MiceXi Zheng, Xiao-Xing Cui, Tin Oo Khor, et al.
Biological & Pharmaceutical Bulletin|August 4, 2017
Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in VivoZhen-Shi Wang, Hua-Rong Huang, Lan-Yue Zhang, et al.
Journal of Oncology Practice|May 3, 2011
Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panelSusan Goodin, Niesha Griffith, Beth Chen, et al.
Anticancer Research|July 2, 2014
Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivoHuarong Huang, Xiao-Xing Cui, Shaohua Chen, et al.
Oncology Reports|December 4, 2013
Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxibHuaqian Wang, Xiao-Xing Cui, Susan Goodin, et al.
European Journal of Pharmacology|December 28, 2020
Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cellsXue-Tao Xu, Jie Chen, Xiang Ren, et al.
Investigational New Drugs|August 8, 2019
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumorsMark N Stein, Susan Goodin, Murugeson Gounder, et al.
Journal of Agricultural and Food Chemistry|October 17, 2014
Potent inhibitory effect of δ-tocopherol on prostate cancer cells cultured in vitro and grown as xenograft tumors in vivoHuarong Huang, Yan He, Xiao-Xing Cui, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 19, 2014
Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trialJohn P Richie, Arun Das, Ana M Calcagnotto, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumorsJanice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Pageof 8